RARECAN LIMITED
12844377Research and experimental development on biotechnology
RARECAN LIMITED
Research and experimental development on biotechnology
Previous Company Names
Contact & Details
Contact
Registered Address
8 Park Avenue Hexham Northumberland NE46 3EN United Kingdom
Full company profile for RARECAN LIMITED (12844377), an active life sciences and medical technology company based in Hexham, United Kingdom. Incorporated 28 Aug 2020. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2021–2025)
Cash in Bank
£53.92k
Net Assets
£48.26k
Total Liabilities
£24.90k
Turnover
N/A
Employees
7
Debt Ratio
34%
Financial History
Revenue, profit, EBITDA and key financial figures
2025 31 Aug Year End | 2024 31 Aug Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
Investors (6)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 4 | Mar 2021 | Seed |
| Investor 5 | Mar 2021 | Seed |
| Investor 6 | Mar 2021 | Seed |
See all 6 investors
Sign up to view complete investor information
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Amanda Elisabeth Owen Gibbon | Director | British | England | 10 Dec 2020 | Active |
| Simon Allocca | Director | British | England | 28 Aug 2020 | Active |
See all 7 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (3)
Simon Allocca
British
- Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent
Andrew Graham Hall
British
- Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent
Piers Martin Kotting
British
- Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent
Claire Elizabeth Jane Heron
Ceased 30 Sept 2024
Group Structure
Group Structure
No group structure identified
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 22 Apr 2026 | Officers | Termination of Andrew Graham Hall as director on 29 Jan 2026 | |
| 9 Mar 2026 | Capital | Capital Return Purchase Own Shares | |
| 9 Mar 2026 | Capital | Capital Cancellation Shares | |
| 26 Jan 2026 | Persons With Significant Control | Notification of a person with significant control statement | |
| 21 Jan 2026 | Capital | Capital Cancellation Shares |
Termination of Andrew Graham Hall as director on 29 Jan 2026
Capital Return Purchase Own Shares
Capital Cancellation Shares
Notification of a person with significant control statement
Capital Cancellation Shares
Recent Activity
Latest Activity
Termination of Andrew Graham Hall as director on 29 Jan 2026
1 months ago on 22 Apr 2026
Capital Return Purchase Own Shares
3 months ago on 9 Mar 2026
Capital Cancellation Shares
3 months ago on 9 Mar 2026
Notification of a person with significant control statement
4 months ago on 26 Jan 2026
Capital Cancellation Shares
4 months ago on 21 Jan 2026